Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
at a similar level in another Irish HEI Researcher Career Development Framework | Irish Universities Association Project Title: Programme of Research into Safe Nurse Staffing and Skill-Mix. Post Duration
-
support to the PI and to support the Dept of General Practice research and education activities, including the development of undergraduate GP curriculum content. It is a part time (2 days) per week post
-
Positions Country Ireland Application Deadline 11 Dec 2025 - 12:00 (Europe/Dublin) Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by
-
must have strong interpersonal and leadership qualities and be capable of developing and mentoring less experienced staff. The successful candidate will be expected to take a leading role in staff
-
be capable of developing and mentoring less experienced staff. The successful candidate will be expected to take a leading role in staff education programmes in the CRF-UCC. Project Title: CRF UCC Post
-
that researcher ineligible for appointment at a similar level in another Irish HEI Researcher Career Development Framework | Irish Universities Association Project Title: Industry-funded project on the early life
-
, data management, data analysis and reporting. The development and deployment of electronic data capture (EDC) tools, including REDCap, are central to these supports. To meet growing demand in this area
-
Fixed Term Whole Time Post (duration to 15th July 2028) UCC wishes to appoint an experienced Occupational Therapist to support the ongoing dynamic development of the mental health services provided
-
details of the post see https://ore.ucc.ie/ Informal enquiries can be made in confidence to Dr Harry Nguyen, Programme Director, Insight Centre for Data Analytics. Email: hn@cs.ucc.ie Applications must be
-
Horizon Europe project GENEGUT. This project aims to develop a first-in-class, orally administered RNA-based therapy for ileal Crohn’s disease which selectively targets novel nucleic acid-based therapeutic